Efficacy and safety of adrenomedullin for acute ischemic stroke (AMFIS): a phase 2, randomized, double-blinded, placebo-controlled, clinical trial

ABSTRACT:

SUBMITTER: Yoshimoto T 

PROVIDER: S-EPMC11605132 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature